Evotec SE
OTC: EVOTF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Christian Wojczewski
- Employees
- 4,766
- Headquarters
- Hamburg, Germany
- IPO year
- 2009
- Market cap
- $1.2B
- Website
- https://www.evotec.com
Loading EVOTF…
Loading profile data…Frequently asked questions about EVOTF
What does Evotec SE (EVOTF) do?
Evotec SE serves as a prominent global partner, offering comprehensive drug discovery and development services to both the pharmaceutical and biotechnology sectors worldwide. The company is actively involved in advancing pharmaceutical products across a diverse array of therapeutic areas. These encompass, among others, diabetes and its related c...
Where does EVOTF trade?
Evotec SE (EVOTF) trades on the Other OTC.
What sector is EVOTF in?
Evotec SE (EVOTF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Evotec SE?
Christian Wojczewski is the chief executive officer of Evotec SE (EVOTF).
Where is Evotec SE headquartered?
Evotec SE is headquartered in Germany.
Does EVOTF pay a dividend?
Evotec SE (EVOTF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EVOTF go public?
Evotec SE (EVOTF) completed its initial public offering in 2009.